Rutgers Launches Lyme Disease Vaccine Study.

Rutgers Launches Lyme Disease Vaccine Study.

The university is participating in the effort to determine the efficacy of what could be the first vaccine to prevent Lyme disease in children ages 5 to 17. Rutgers has been selected as a clinical trial site for the national research study by drug company Pfizer Inc....

New NJACTS Publication

Please read Dr. Blaser’s article in Cancer Cell titled, “Tumor microbiome links cellular programs and immunity in pancreatic cancer.” The microbiome contributes to human health and disease, including oncogenesis. Although it is uncertain whether the...